Description
Otixal, a prescription ear drop medication, combines ciprofloxacin and fluocinolone, offering a dual-action approach to address various ear conditions, specifically targeting infections and inflammation within the ear.
Otixal is indicated for treating acute otitis media (ear infection) in pediatric patients aged six months and older. It demonstrates efficacy in eliminating specific bacteria responsible for causing ear infections.
Directions
Administration:
Otixal is supplied in single-use vials. To administer, tilt the head to the side and instill the contents of one vial into the ear. Gently pump the small cartilage in front of the ear canal four times to facilitate the penetration of medication into the ear. Maintain the head tilted for one minute with the medication in the ear.
Dosage:
Follow the prescribed dosage and duration of treatment as directed by your healthcare provider. Do not discontinue the treatment before completing the full course. If you have any concerns or questions, consult your doctor.
Monitoring:
Inform your doctor if symptoms persist beyond seven days of treatment.
Ingredients
Ciprofloxacin: An antibiotic combating bacteria in the ear by inhibiting their growth and spread.
Fluocinolone: A corticosteroid that reduces inflammation, relieving pain and swelling.
Interactions
Common drug-drug interactions with this medication may include:
- Agomelatine
- Bepridil
- Cisapride
- Desmopressin
- Dronedarone
- Eliglustat
- Fezolinetant
- Flibanserin
- Levoketoconazole
- Mesoridazine
- Pimozide
- Piperaquine
- Saquinavir
- Sparfloxacin
- Terfenadine
- Thioridazine
- Tizanidine
- Ziprasidone
Cautions
Inform your doctor about allergies or sensitivities, and discontinue the drug if a skin rash develops.
Promptly contact your healthcare provider for any unusual side effects or discomfort.
Adhere strictly to your doctor’s prescribed duration; do not use Otixal for a more extended period than recommended.
Side Effects
The most common adverse effects are:
- Auricular swelling
- Balance disorder
- Ear infection
- Ear pruritus
- Excessive granulation tissue
- Hypersensitivity reaction
- Opportunistic infection
- Otorrhea
- Tympanic membrane disorder
References
Otixal [package insert]. Verdun, QC: Pediapharm Inc; April 2018.
About Dr. Conor Sheehy (Page Author)
Dr. Sheehy (BSc Molecular Biology, PharmD) works a clinical pharmacist specializing in cardiology, oncology, and ambulatory care. He’s a board-certified pharmacotherapy specialist (BCPS), and his experience working one-on-one with patients to fine tune their medication and therapy plans for optimal results makes him a valuable subject matter expert for our pharmacy. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 14417